Nuove prospettive nella riduzione del rischio cardiovascolare

Focus su HDL

Translated title of the contribution: New perspectives in cardiovascular risk reduction: Focus on HDL

Stefania Paolillo, Giuseppe Luca Della Ratta, Alice Vitagliano, Annapaola Cirillo, Elisabetta Lardino, Tiziana Formisano, Irma Fabiani, Angela Maria Pellegrino, Pietro Riello, Pasquale Perrone Filardi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide, mostly contributing to hospitalizations and health care costs. Dyslipidemias represent one of the major cardiovascular risk factor and its management, throughout life-style modifications and pharmacological interventions, has shown to reduce cardiac events. The risk of adverse cardiovascular events is related not only to elevated LDL blood levels, but also to decreased HDL concentrations, that exhibit protective effects in the development of atherosclerotic process. Aim of this review is to summarize current evidences about defensing effects of such lipoproteins and to show the most recent pharmacological strategies to reduce cardiovascular risk through the increase of their circulating levels.

Original languageItalian
Pages (from-to)27-30
Number of pages4
JournalMonaldi Archives for Chest Disease - Cardiac Series
Volume80
Issue number1
Publication statusPublished - Mar 2013

Fingerprint

Risk Reduction Behavior
Pharmacology
Dyslipidemias
Health Care Costs
Lipoproteins
Life Style
Hospitalization
Cardiovascular Diseases
Morbidity
Mortality
oxidized low density lipoprotein

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Paolillo, S., Della Ratta, G. L., Vitagliano, A., Cirillo, A., Lardino, E., Formisano, T., ... Perrone Filardi, P. (2013). Nuove prospettive nella riduzione del rischio cardiovascolare: Focus su HDL. Monaldi Archives for Chest Disease - Cardiac Series, 80(1), 27-30.

Nuove prospettive nella riduzione del rischio cardiovascolare : Focus su HDL. / Paolillo, Stefania; Della Ratta, Giuseppe Luca; Vitagliano, Alice; Cirillo, Annapaola; Lardino, Elisabetta; Formisano, Tiziana; Fabiani, Irma; Pellegrino, Angela Maria; Riello, Pietro; Perrone Filardi, Pasquale.

In: Monaldi Archives for Chest Disease - Cardiac Series, Vol. 80, No. 1, 03.2013, p. 27-30.

Research output: Contribution to journalArticle

Paolillo, S, Della Ratta, GL, Vitagliano, A, Cirillo, A, Lardino, E, Formisano, T, Fabiani, I, Pellegrino, AM, Riello, P & Perrone Filardi, P 2013, 'Nuove prospettive nella riduzione del rischio cardiovascolare: Focus su HDL', Monaldi Archives for Chest Disease - Cardiac Series, vol. 80, no. 1, pp. 27-30.
Paolillo S, Della Ratta GL, Vitagliano A, Cirillo A, Lardino E, Formisano T et al. Nuove prospettive nella riduzione del rischio cardiovascolare: Focus su HDL. Monaldi Archives for Chest Disease - Cardiac Series. 2013 Mar;80(1):27-30.
Paolillo, Stefania ; Della Ratta, Giuseppe Luca ; Vitagliano, Alice ; Cirillo, Annapaola ; Lardino, Elisabetta ; Formisano, Tiziana ; Fabiani, Irma ; Pellegrino, Angela Maria ; Riello, Pietro ; Perrone Filardi, Pasquale. / Nuove prospettive nella riduzione del rischio cardiovascolare : Focus su HDL. In: Monaldi Archives for Chest Disease - Cardiac Series. 2013 ; Vol. 80, No. 1. pp. 27-30.
@article{528ff44330284bf9866cb5bca11d8353,
title = "Nuove prospettive nella riduzione del rischio cardiovascolare: Focus su HDL",
abstract = "Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide, mostly contributing to hospitalizations and health care costs. Dyslipidemias represent one of the major cardiovascular risk factor and its management, throughout life-style modifications and pharmacological interventions, has shown to reduce cardiac events. The risk of adverse cardiovascular events is related not only to elevated LDL blood levels, but also to decreased HDL concentrations, that exhibit protective effects in the development of atherosclerotic process. Aim of this review is to summarize current evidences about defensing effects of such lipoproteins and to show the most recent pharmacological strategies to reduce cardiovascular risk through the increase of their circulating levels.",
keywords = "Cardiovascular risk, Dyslipidemia, HDL",
author = "Stefania Paolillo and {Della Ratta}, {Giuseppe Luca} and Alice Vitagliano and Annapaola Cirillo and Elisabetta Lardino and Tiziana Formisano and Irma Fabiani and Pellegrino, {Angela Maria} and Pietro Riello and {Perrone Filardi}, Pasquale",
year = "2013",
month = "3",
language = "Italian",
volume = "80",
pages = "27--30",
journal = "Monaldi Archives for Chest Disease",
issn = "1122-0643",
publisher = "Fondazione Salvatore Maugeri",
number = "1",

}

TY - JOUR

T1 - Nuove prospettive nella riduzione del rischio cardiovascolare

T2 - Focus su HDL

AU - Paolillo, Stefania

AU - Della Ratta, Giuseppe Luca

AU - Vitagliano, Alice

AU - Cirillo, Annapaola

AU - Lardino, Elisabetta

AU - Formisano, Tiziana

AU - Fabiani, Irma

AU - Pellegrino, Angela Maria

AU - Riello, Pietro

AU - Perrone Filardi, Pasquale

PY - 2013/3

Y1 - 2013/3

N2 - Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide, mostly contributing to hospitalizations and health care costs. Dyslipidemias represent one of the major cardiovascular risk factor and its management, throughout life-style modifications and pharmacological interventions, has shown to reduce cardiac events. The risk of adverse cardiovascular events is related not only to elevated LDL blood levels, but also to decreased HDL concentrations, that exhibit protective effects in the development of atherosclerotic process. Aim of this review is to summarize current evidences about defensing effects of such lipoproteins and to show the most recent pharmacological strategies to reduce cardiovascular risk through the increase of their circulating levels.

AB - Cardiovascular diseases represent the leading cause of morbidity and mortality worldwide, mostly contributing to hospitalizations and health care costs. Dyslipidemias represent one of the major cardiovascular risk factor and its management, throughout life-style modifications and pharmacological interventions, has shown to reduce cardiac events. The risk of adverse cardiovascular events is related not only to elevated LDL blood levels, but also to decreased HDL concentrations, that exhibit protective effects in the development of atherosclerotic process. Aim of this review is to summarize current evidences about defensing effects of such lipoproteins and to show the most recent pharmacological strategies to reduce cardiovascular risk through the increase of their circulating levels.

KW - Cardiovascular risk

KW - Dyslipidemia

KW - HDL

UR - http://www.scopus.com/inward/record.url?scp=84887890948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887890948&partnerID=8YFLogxK

M3 - Articolo

VL - 80

SP - 27

EP - 30

JO - Monaldi Archives for Chest Disease

JF - Monaldi Archives for Chest Disease

SN - 1122-0643

IS - 1

ER -